ChinaBio® Today Articles

Welcome to the ChinaBio® Today store. As a service to our readers, we offer access to individual articles for only $5.00 (USD) each.  Of course, a subscription is only $20/mo, so you may prefer to subscribe.  If so, click on Subscribe in the menu.

Browse


All Products

Viewing 3946 - 3960 of 5996 products
Ascletis Reports Positive Phase II Data from Interferon-free HCV Regimen
$5.00
Available
China Announces Overview for Healthcare Big Data Project
$5.00
Available
Chi-Med Earns $10 Million Milestone from AstraZeneca in Lung Cancer Trial
$5.00
Available
China Life Insurance Restarts Takover Battle for iKang
$5.00
Available
Wuhan Humanwell Building $80 Million Production Facility in Ethiopia
$5.00
Available
Shenzhen Hepalink Invests $60 Million in Latest TPG Biotech Fund
$5.00
Available
Gan & Lee Plans $226 Million China IPO
$5.00
Available
Response Biomedical of Canada Taken Private by OrbiMed and China IVD Maker
$5.00
Available
China Begins Marketing Authorization Holder Pilot Program
$5.00
Available
Vivo Capital Closes $100 Million Fund for Early-Stage US-China Healthcare Companies
$5.00
Available
TaiGen Biotech's Novel Antibiotic Approved for Use in China
$5.00
Available
Innovent Expands Adimab Partnership; Second mAb Partnership in a Week
$5.00
Available
Parkway Pantai Building $70 Million Hospital in Shanghai
$5.00
Available
Galmed Pharma Adds China Arm to Phase IIb Trial of Liver Disease Drug
$5.00
Available
Yunfeng Capital/Alibaba Wins $1.6 Billion Takeover Battle for iKang Healthcare
$5.00
Available